Tag: Diabetes

Zydus Lifesciences gets FDA tentative approval for Invokamet generic

businessnewstoday- February 22, 2023

Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has been granted tentative approval for Canagliflozin and Metformin Hydrochloride Tablets, 50mg/500mg, 50mg/1,000mg, 150mg/500mg, and 150mg/1,000mg ... Read More

Glenmark Pharmaceuticals gets FDA second tentative approval for Saxagliptin Tablets

businessnewstoday- February 17, 2023

Glenmark Pharmaceuticals Inc., USA has secured a second tentative approval from the United States Food and Drug Administration (FDA) for Saxagliptin Tablets, 2.5 mg and ... Read More

Insulin patch pump developer AMF Medical to be acquired by Tandem Diabetes Care

Raghuram Kadari- December 15, 2022

Tandem Diabetes Care, an American diabetes technology company, has agreed to acquire Switzerland-based insulin patch pump developer AMF Medical SA for CHF 62.4 million, which ... Read More

Zydus Lifesciences gets FDA final approvals for Silodosin and Pregabalin capsules

businessnewstoday- December 10, 2022

Zydus Lifesciences (formerly known as Cadila Healthcare) has secured final approvals from the US Food and Drug Administration (FDA) for Silodosin Capsules, 4 mg and ... Read More

Biocon partners with Zentiva for European marketing of Liraglutide

businessnewstoday- November 29, 2022

Biocon Limited has entered into a semi-exclusive partnership with Zentiva, a Czech pharma company for marketing its drug-device combination Liraglutide for the treatment and management ... Read More

Glenmark Pharmaceuticals launches Type 2 diabetes drug Zita D in India

businessnewstoday- October 20, 2022

Glenmark Pharmaceuticals has launched Zita D the brand name for Teneligliptin (20mg) + Dapagliflozin (5mg/10mg) fixed dose combination in India for the treatment of Type ... Read More

Zydus Lifesciences launches diabetes drugs Sitaglyn and Siglyn in India

- July 10, 2022

Zydus Lifesciences (Cadila Healthcare) has rolled out the molecule Sitagliptin in India under the Sitaglyn and Siglyn brand names for the treatment of Type 2 ... Read More

FDA issues warning letter to Medtronic diabetes business

businessnewstoday- December 15, 2021

Medtronic said that it has been issued a warning letter from the US Food and Drug Administration (FDA) for its facility in Northridge, California, which ... Read More

Cipla signs licensing deal with Lilly to sell two diabetes drugs in India

- October 4, 2021

Cipla has signed a licensing deal with the Indian subsidiary of US pharma giant Eli Lilly and Company (Lilly) pertaining to the latter’s diabetes treatments ... Read More

Lilly takes full ownership of biotech company Protomer Technologies

- July 14, 2021

Eli Lilly and Company (Lilly) has taken full ownership of California-based biotech company Protomer Technologies in a deal that is potentially worth more than $1 ... Read More